You are here: Industry Insights > diabetes

News List

Removable implant may control type 1 diabetes europeanpharmaceuticalreview
January 04, 2018
Researchers have devised a method for implanting islet cells into a patient that may control the management of type 1 diabetes…
Xultophy(R) Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for Peop prnasia
December 12, 2017
Regardless of which treatment the study participants were switched from, the average decrease in blood sugar was significant.[1]
FDA Approves OZEMPIC Injection for Type 2 Diabetes americanpharmaceuticalreview
December 07, 2017
Novo Nordisk announced theFDA approved its New Drug Application for OZEMPIC injection 0.5 mg or 1 mg, a once-weekly glucagon-like peptide receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 di
Massachusetts' Fractyl Bags $44M to Advance New Treatment for Type 2 Diabetes biospace
December 01, 2017
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
First made-in-India ‘digital pill’ to undergo clinical trial for diabetes expressbpd
November 16, 2017
The #WeDiDiT (Wellthy Digital Diabetes Therapy) trial is all set to prove the efficacy of its 16-week structured diabetes management programme delivered through a mobile app.
NHS backs innovative means of cutting diabetes risk pharmafile
November 16, 2017
It was World Diabetes Day yesterday and the NHS announced a new tech initiative to help those most at risk of developing type 2 diabetes. It was revealed that more than 5,000 people will be enrolled to test apps tracking physical activity and other health
Poxel, Sumitomo Dianippon Pharma ink $300 mn Asian deal for diabetes drug biospectrumasia
November 02, 2017
The partnership enables Sumitomo Dainippon Pharma to add an innovative late-stage development product to its diabetes pipeline
GP referrals to Weight Watchers cut diabetes risk pharmatimes
October 19, 2017
More than one third of patients referred by GPs to Weight Watchers in a bid to stave off diabetes saw their blood sugar levels return to normal, a study published in the British Medical Journal has found.
Oral semaglutide shows promise for type 2 diabetes europeanpharmaceuticalreview
October 18, 2017
Researchers have identified that the drug semaglutide resulted in better glycemic control than placebo for patients with type 2 diabetes…
Type 2 diabetes drug provides significant benefits to type 1 diabetic patients europeanpharmaceuticalreview
September 15, 2017
A study has found that a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels…

Previous page 1 2 Next page